Cure Today1h
FDA Accepts NDA For Dordaviprone in H3 K27M-Mutant Diffuse Glioma
A New Drug Application has been accepted seeking accelerated approval for dordaviprone for patients with recurrent H3 ...
Cure Today3h
FDA Accepts Priority Review for Pre- and Postsurgical Keytruda in HNSCC
The FDA accepted for priority review a supplemental Biologics License Application for Keytruda for resectable locally ...
Cure Today5h
Treating Lymphedema with a Simple Trinket
My relationship with lymphedema has been more complicated than my relationship with the mastectomy. While I am less stressed ...
Cure Today7h
Some KRAS Mutations Associated With Worse Outcomes in Pancreatic Cancer
In patients with pancreatic ductal adenocarcinoma, KRAS G12D and G12V mutations hare associated with worse patient outcomes, ...
Cure Today6h
Understanding Biliary Tract Cancer and The Current Standard of Care
An expert explains what biliary tract cancers are and the current landscape of treatment as well as future advancements.
Cure Today9h
Neoadjuvant Opdivo Combo Elicits Statistically Significant OS Findings in Resectable NSCLC
Neoadjuvant Opdivo with platinum-doublet chemo had a statistically significant and clinically meaningful improvement versus ...